Natural Killer Cell Therapies Market Estimated to Experience a Hike in Growth by 2035
Natural killer (NK) cells are a crucial subset of the innate immune system, known for their role in containing viral infections and regulating tumor development. Unlike B-lymphocytes and T-lymphocytes, NK cells do not require specific antigen-based activation to function. They exert their cytotoxic effects through perforin and granzymes, similar to cytotoxic T cells, and can also secrete cytokines and chemokines like IFNγ and TNFα to augment immune responses.
The market is being evaluated across multiple clinical trials for treating various types of cancer and infectious diseases. Genetic modification of NK cells has shown additional benefits, and companies are developing allogenic product candidates for off-the-shelf therapies.
Read More :- https://www.rootsanalysis.com/....reports/natural-kill
